Blake McAlpin is a Field Application Scientist in the Boston area for ACD. He received his Ph.D. in Neuroscience from MD Anderson UTHealth Graduate School of Biomedical Sciences in 2021 where he studied neurotoxic side effects of chemotherapy treatment with a focus on microglia-mediated mechanisms underlying cognitive dysfunction. His master’s degree from Université Denis Diderot (Paris VII) focused on endocrine disruption by BPA with regard to the endogenous circadian clock. He received his bachelor's degree in Neuroscience from the University of Michigan.
